Therapeutic B cell depletion and regeneration in rheumatoid arthritis: emerging patterns and paradigms.
Silverman
Gregg J
GJ
University of California, San Diego, CA 92093-0663, USA. gsilverman@ucsd.edu
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001402:B-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D008212:Lymphocyte Depletion; D012038:Regeneration / Q000187:drug effects / Q000276:immunology; D012219:Rheumatology / Q000379:methods*; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D018501:Antirheumatic Agents; D000069283:Rituximab